As Alzheimer's disease progresses beyond the early stages, the behavior changes and emotional impacts of the disease can be ...

Each episode of this journey through a disease state contains both a physician guide and a downloadable/printable patient ...

Synendos Therapeutics appoints Dr. George Garibaldi to move phase 2 clinical development of its lead drug asset SYT-510: Basel, Switzerland Wednesday, July 16, 2025, 15:45 Hrs [IS ...

Treatment with memantine in a small cohort of individuals with post-traumatic headache led to fewer average headache days per ...

Synendos Therapeutics (“Synendos”), the clinical-stage biotechnology company developing breakthrough therapies for ...

Overview of Autologous Cell Therapy Product MarketGlobal Cell Therapy Market is valued at USD 10.1 Billion in 2025 and is ...

Today in Music History for July 21: ...

New program combines IV-delivered TRACER capsid with bifunctional payload to silence APOE in carriers of the high-risk APOE4 variant while delivering the protective APOE2 variant - - Voyager's wholly- ...

Acumen and JCR aim to develop a product leveraging Acumen's amyloid beta oligomer-selective antibody expertise and JCR's transferrin-receptor-targeting blood-brain barrier-penetrating technologyPrecli ...

A review of a decade of studies on cardiovascular health found that the benefits of ideal heart health extend beyond the ...

With plenty of new pieces and some lost talent due to graduation, here's what Creighton's rotation could look like for the coming season.